Browse > Article
http://dx.doi.org/10.3961/jpmph.2014.47.4.183

Cancer Control Programs in East Asia: Evidence From the International Literature  

Moore, Malcolm A. (Asian Pacific Journal of Cancer Prevention)
Publication Information
Journal of Preventive Medicine and Public Health / v.47, no.4, 2014 , pp. 183-200 More about this Journal
Abstract
Cancer is a major cause of mortality and morbidity throughout the world, including the countries of North-East and South-East Asia. Assessment of burden through cancer registration, determination of risk and protective factors, early detection and screening, clinical practice, interventions for example in vaccination, tobacco cessation efforts and palliative care all should be included in comprehensive cancer control programs. The degree to which this is possible naturally depends on the resources available at local, national and international levels. The present review concerns elements of cancer control programs established in China, Taiwan, Korea, and Japan in North-East Asia, Viet Nam, Thailand, Malaysia, and Indonesia as representative larger countries of South-East Asia for comparison, using the published literature as a guide. While major advances have been made, there are still areas which need more attention, especially in South-East Asia, and international cooperation is essential if standard guidelines are to be generated to allow effective cancer control efforts throughout the Far East.
Keywords
Cancer control programs; Registration; Screening; Tobacco control; Vaccination; East Asia;
Citations & Related Records
Times Cited By KSCI : 33  (Citation Analysis)
연도 인용수 순위
1 Kweon SS, Shin MH, Chung IJ, Kim YJ, Choi JS. Thyroid cancer is the most common cancer in women, based on the data from population-based cancer registries, South Korea. Jpn J Clin Oncol 2013;43(10):1039-1046.   DOI
2 Tanaka H, Tanaka M, Chen W, Park S, Jung KW, Chiang CJ, et al. Proposal for a cooperative study on population-based cancer survival in selected registries in East Asia. Asian Pac J Cancer Prev 2009;10(6):1191-1198.
3 Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T, et al. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol 2011;41(1):40-51.   DOI   ScienceOn
4 Jung KW, Won YJ, Kong HJ, Oh CM, Shin A, Lee JS. Survival of korean adult cancer patients by stage at diagnosis, 2006-2010: national cancer registry study. Cancer Res Treat 2013;45(3):162-171.   DOI   ScienceOn
5 Katayama K, Yokoyama K, Yako-Suketomo H, Okamoto N, Tango T, Inaba Y. Breast cancer clustering in kanagawa, Japan: a geographic analysis. Asian Pac J Cancer Prev 2014;15(1):455-460.   DOI   ScienceOn
6 Shah SA, Neoh HM, Rahim SS, Azhar ZI, Hassan MR, Safian N, et al. Spatial analysis of colorectal cancer cases in Kuala Lumpur. Asian Pac J Cancer Prev 2014;15(3):1149-1154.   DOI   ScienceOn
7 Ito Y, Nakayama T, Miyashiro I, Sugimoto T, Ioka A, Tsukuma H, et al. Trends in 'cure' fraction from colorectal cancer by age and tumour stage between 1975 and 2000, using population-based data, Osaka, Japan. Jpn J Clin Oncol 2012;42(10):974-983.   DOI
8 Soon SS, Lim HY, Lopes G, Ahn J, Hu M, Ibrahim HM, et al. Roles of cancer registries in enhancing oncology drug access in the Asia-Pacific region. Asian Pac J Cancer Prev 2013;14(4):2159-2165.   DOI   ScienceOn
9 Khuhaprema T, Sangrajrang S, Lalitwongsa S, Chokvanitphong V, Raunroadroong T, Ratanachu-Ek T, et al. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme. BMJ Open 2014;4(1):e003671.   DOI
10 Minamimoto R, Senda M, Jinnouchi S, Terauchi T, Yoshida T, Inoue T. Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey. Jpn J Radiol 2014;32(5):253-259.   DOI
11 Choi KS, Lee HY, Jun JK, Shin A, Park EC. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol 2012;27(6):1070-1077.   DOI
12 Kim Y, Jun JK, Choi KS, Lee HY, Park EC. Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev 2011;12(3):725-730.
13 Song P, Feng X, Zhang K, Song T, Ma K, Kokudo N, et al. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China. Biosci Trends 2013;7(1):1-6.
14 Kitagawa Y, Mizokami A, Namiki M. Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening. Prostate Int 2013;1(2):65-68.   DOI
15 Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002;94(19):1445-1457.   DOI   ScienceOn
16 Kardinah D, Anderson BO, Duggan C, Ali IA, Thomas DB. Short report: limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia. Int J Cancer 2014;134(5):1250-1255.   DOI
17 American Institute for Cancer Research, World Cancer Research Fund. Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007.
18 Tanaka H. Advances in cancer epidemiology in Japan. Int J Cancer 2014;134(4):747-754.   DOI
19 Yoo KY. Cancer control activities in the Republic of Korea. Jpn J Clin Oncol 2008;38(5):327-333.   DOI   ScienceOn
20 Roder D. What roles should population-based cancer registries be playing in the 21st century? Reflections on the Asian Cancer Registry Forum, Bangkok, February 2014. Asian Pac J Cancer Prev 2014;15(5):1895-1896.   DOI
21 Moore MA, Sobue T. Strategies for cancer control on an organ-site basis. Asian Pac J Cancer Prev 2010;11 Suppl 2:149-164.
22 Inoue M, Sawada N, Matsuda T, Iwasaki M, Sasazuki S, Shimazu T, et al. Attributable causes of cancer in Japan in 2005: systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan. Ann Oncol 2012;23(5):1362-1369.   DOI   ScienceOn
23 Oh IH, Yoon SJ, Yoon TY, Choi JM, Choe BK, Kim EJ, et al. Health and economic burden of major cancers due to smoking in Korea. Asian Pac J Cancer Prev 2012;13(4):1525-1531.   DOI
24 Liang H, Wang J, Xiao H, Wang D, Wei W, Qiao Y, et al. Estimation of cancer incidence and mortality attributable to alcohol drinking in China. BMC Public Health 2010;10:730.   DOI   ScienceOn
25 Wang JB, Jiang Y, Wei WQ, Yang GH, Qiao YL, Boffetta P. Estimation of cancer incidence and mortality attributable to smoking in China. Cancer Causes Control 2010;21(6):959-965.   DOI
26 Shin A, Jung YS, Jung KW, Kim K, Ryu J, Won YJ. Trends of human papillomavirus-related head and neck cancers in Korea: national cancer registry data. Laryngoscope 2013;123(11):E30-E37.   DOI
27 Lau HY, Leung CM, Chan YH, Lee AW, Kwong DL, Lung ML, et al. Secular trends of salted fish consumption and nasopharyngeal carcinoma: a multi-jurisdiction ecological study in 8 regions from 3 continents. BMC Cancer 2013;13:298.   DOI   ScienceOn
28 Morimoto T, Tangoku A, Yamakawa T, Tsuruno M, Takashima S. Promotion of quality-controlled mammography alone as a screening modality in Japan. Breast Cancer 2014;21(4):435-441.   DOI
29 Pisani P, Parkin DM, Ngelangel C, Esteban D, Gibson L, Munson M, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006;118(1):149-154.   DOI   ScienceOn
30 Wang B, He M, Wang L, Engelgau MM, Zhao W, Wang L. Bre-ast cancer screening among adult women in China, 2010. Prev Chronic Dis 2013;10:E183.
31 Wang FL, Chen F, Yin H, Xu N, Wu XX, Ma JJ, et al. Effects of age, breast density and volume on breast cancer diagnosis: a retrospective comparison of sensitivity of mammography and ultrasonography in China's rural areas. Asian Pac J Cancer Prev 2013;14(4):2277-2282.   DOI   ScienceOn
32 Khuhaprema T, Attasara P, Srivatanakul P, Sangrajrang S, Muwonge R, Sauvaget C, et al. Organization and evolution of organized cervical cytology screening in Thailand. Int J Gynaecol Obstet 2012;118(2):107-111.   DOI
33 Kasinpila C, Promthet S, Vatanasapt P, Sasieni P, Parkin DM. Evaluation of the nationwide cervical screening programme in Thailand: a case-control study. J Med Screen 2011;18(3):147-153.   DOI
34 Kim YM, Ati A, Kols A, Lambe FM, Soetikno D, Wysong M, et al. Influencing women's actions on cervical cancer screening and treatment in Karawang District, Indonesia. Asian Pac J Cancer Prev 2012;13(6):2913-2921.   DOI
35 Qiao YL, Jeronimo J, Zhao FH, Schweizer J, Chen W, Valdez M, et al. Lower cost strategies for triage of human papillomavirus DNA-positive women. Int J Cancer 2014;134(12):2891-2901.   DOI
36 Muir CS, Waterhouse J, Mack T, Powell J, Whelan SL. Cancer incidence in five continents. Lyon: International Agency for Research on Cancer; 1987.
37 Monden M. The basic plan to promote cancer control in Japan. Gan To Kagaku Ryoho 2013;40(5):559-564 (Japanese).
38 Bridges JF, Joy SM, Gallego G, Kudo M, Ye SL, Han KH, et al. Needs for hepatocellular carcinoma control policy in the Asia-Pacific region. Asian Pac J Cancer Prev 2011;12(10):2585-2591.
39 Waterhouse JA, Muir CS, Powell J, Shanmugaratnam K, Peacham D, Whelan S, et al. Cancer incidence in five continents. Vol. IV. Lyon: International Agency for Research on Cancer; 1982.
40 Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer incidence in five continents. Vol. VI. Lyon: International Agency for Research on Cancer; 1992.
41 Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. Vol. VII. Lyon: International Agency for Research on Cancer; 1997.
42 Parkin, DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Vol. VIII. Lyon: International Agency for Research on Cancer; 2002.
43 Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents. Vol. IX. Lyon: International Agency for Research on Cancer; 2007.
44 Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pineros M, et al. Cancer incidence in five continents. Vol. X [cited 2014 Jul 21]. Available from: http://ci5.iarc.fr.
45 Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. Lyon: IARCPress; 2004.
46 Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [cited 2014 Jul 21]. Available from: http://globocan.iarc.fr.
47 Kimman M, Norman R, Jan S, Kingston D, Woodward M. The burden of cancer in member countries of the Association of Southeast Asian Nations (ASEAN). Asian Pac J Cancer Prev 2012;13(2):411-420.   DOI
48 Dondog B, Lise M, Dondov O, Baldandorj B, Franceschi S. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia. Eur J Cancer Prev 2011;20(1):33-39.   DOI   ScienceOn
49 Tokudome S, Samsuria Soeripto WD, Triningsih FX, Suzuki S, Hosono A, Triono T, et al. Helicobacter pylori infection appears essential for stomach carcinogenesis: observations in Semarang, Indonesia. Cancer Sci 2005;96(12):873-875.   DOI
50 Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009;101(19):1348-1355.   DOI   ScienceOn
51 Hayashi Y, Shimizu Y, Netsu S, Hanley S, Konno R. High HPV vaccination uptake rates for adolescent girls after regional governmental funding in Shiki City, Japan. Vaccine 2012;30(37):5547-5550.   DOI
52 Al-Naggar RA, Bobryshev YV, Al-Jashamy K, Al-Musli M. Practice of HPV vaccine and associated factors among school girls in Melaka, Malaysia. Asian Pac J Cancer Prev 2012;13(8):3835-3840.   DOI   ScienceOn
53 Ezat SW, Hod R, Mustafa J, Mohd Dali AZ, Sulaiman AS, Azman A. National HPV immunisation programme: knowledge and acceptance of mothers attending an obstetrics clinic at a teaching hospital, Kuala Lumpur. Asian Pac J Cancer Prev 2013;14(5):2991-2999.   DOI   ScienceOn
54 Rashwan HH, Saat NZ, Abd Manan DN. Knowledge, attitude and practice of malaysian medical and pharmacy students towards human papillomavirus vaccination. Asian Pac J Cancer Prev 2012;13(5):2279-2283.   DOI   ScienceOn
55 Mackay J, Ritthiphakdee B, Reddy KS. Tobacco control in Asia. Lancet 2013;381(9877):1581-1587.   DOI
56 Thongkhamcharoen R, Phungrassami T, Atthakul N. Regulation of opioid drugs in thai government hospitals: Thailand national survey 2012. Indian J Palliat Care 2014;20(1):6-11.   DOI
57 Kim YM, Lambe FM, Soetikno D, Wysong M, Tergas AI, Rajbhandari P, et al. Evaluation of a 5-year cervical cancer prevention project in Indonesia: opportunities, issues, and challenges. J Obstet Gynaecol Res 2013;39(6):1190-1199.   DOI
58 Akaza H, Kawahara N, Roh JK, Inoue H, Park EC, Lee KS, et al. Japanese Cancer Association Meeting UICC International session: what is cost-effectiveness in cancer treatment? Asian Pac J Cancer Prev 2014;15(1):3-10.   DOI
59 Phungrassami T, Thongkhamcharoen R, Atthakul N. Palliative care personnel and services: a national survey in Thailand 2012. J Palliat Care 2013;29(3):133-139.
60 Maeda I, Tsuneto S, Miyashita M, Morita T, Umeda M, Motoyama M, et al. Progressive development and enhancement of palliative care services in Japan: nationwide surveys of designated cancer care hospitals for three consecutive years. J Pain Symptom Manage 2014. http://dx.doi.org/10.1016/j.jpainsymman.2013.09.017.
61 Yun YH, Lee MK, Bae Y, Shon EJ, Shin BR, Ko H, et al. Efficacy of a training program for long-term disease- free cancer survivors as health partners: a randomized controlled trial in Korea. Asian Pac J Cancer Prev 2013;14(12):7229-7235.   DOI   ScienceOn
62 Li J, Davis MP, Gamier P. Palliative medicine: barriers and developments in mainland China. Curr Oncol Rep 2011;13(4):290-294.   DOI
63 Morita T, Miyashita M, Yamagishi A, Akizuki N, Kizawa Y, Shirahige Y, et al. A region-based palliative care intervention trial using the mixed-method approach: Japan OPTIM study. BMC Palliat Care 2012;11:2.   DOI
64 Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, et al. The incidences and mortalities of major cancers in China, 2009. Chin J Cancer 2013;32(3):106-112.   DOI
65 Chaleunvong K, Kamsa-Ard S, Suwanrungruang K, Wiangnon S, Sychareun V, Alounlangsy P, et al. Retrospective appraisal of cancer patients from Vientiane Capital City, Lao People's Democratic Republic (PDR), seeking treatment in Thailand. Asian Pac J Cancer Prev 2013;14(9):5435-5440.   DOI
66 Wahidin M, Noviani R, Hermawan S, Andriani V, Ardian A, Djarir H. Population-based cancer registration in Indonesia. Asian Pac J Cancer Prev 2012;13(4):1709-1710.   DOI   ScienceOn
67 Sandagdorj T, Sanjaajamts E, Tudev U, Oyunchimeg D, Ochir C, Roder D. Cancer incidence and mortality in Mongolia: National Registry Data. Asian Pac J Cancer Prev 2010;11(6):1509-1514.
68 Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45(1):1-14.   DOI   ScienceOn
69 Utada M, Ohno Y, Soda M, Kamo K. Estimation of cancer incidence in Japan with an age-period-cohort model. Asian Pac J Cancer Prev 2010;11(5):1235-1240.
70 Li GL, Chen WQ. Representativeness of population-based cancer registration in China: comparison of urban and rural areas. Asian Pac J Cancer Prev 2009;10(4):559-564.
71 Ngoan le T, Lua NT, Hang LT. Cancer mortality pattern in Viet Nam. Asian Pac J Cancer Prev 2007;8(4):535-538.
72 Nguyen TL, Nguyen DC, Nguyen TH, Vu TT, Lai TM, Le TL, et al. Survey-based cancer mortality in the Lao PDR, 2007-08. Asian Pac J Cancer Prev 2011;12(10):2495-2498.
73 Kengkarnpanich M, Termsirikulchai L, Benjakul S. Policy measures on strengthening and developing capabilities for national tobacco control in Thailand. J Med Assoc Thai 2012;95 Suppl 6:S61-S70.
74 Sakuta M. Tobacco control in Japan: what it is, and what it should be. Nihon Rinsho 2013;71(3):399-405 (Japanese).
75 Kashiwabara M, Armada F, Yoshimi I. Kanagawa, Japan's tobacco control legislation: a breakthrough? Asian Pac J Cancer Prev 2011;12(8):1909-1916.
76 Hu TW, Lee AH, Mao Z. WHO Framework Convention on Tobacco Control in China: barriers, challenges and recommendations. Glob Health Promot 2013;20(4):13-22.
77 Sirirassamee T, Sirirassamee B. Trends in tobacco use among Thai adolescents. J Med Assoc Thai 2013;96 Suppl 1:S78-S84.
78 Katanoda K, Saika K, Yamamoto S, Tanaka S, Oshima A, Nakamura M, et al. Projected cancer mortality among Japanese males under different smoking prevalence scenarios: evidence for tobacco control goal setting. Jpn J Clin Oncol 2011;41(4):483-489.   DOI
79 Ngoan le T. Anti-smoking initiative and decline in incidence rates of lung cancer in Viet Nam. Asian Pac J Cancer Prev2006;7(3):492-494.
80 Katanoda K, Jiang Y, Park S, Lim MK, Qiao YL, Inoue M. Tobacco control challenges in East Asia: proposals for change in the world's largest epidemic region. Tob Control 2014;23(4):359-368.   DOI
81 Shin JY, Kim SY, Lee KS, Lee SI, Ko Y, Choi YS, et al. Costs during the first five years following cancer diagnosis in Korea. Asian Pac J Cancer Prev 2012;13(8):3767-3772.   DOI   ScienceOn
82 Moore MA, Attasara P, Khuhaprema T, Le TN, Nguyen TH, Raingsey PP, et al. Cancer epidemiology in mainland South-East Asia: past, present and future. Asian Pac J Cancer Prev 2010;11 Suppl 2:67-80.
83 Moore MA, Shin HR, Curado MP, Sobue T. Establishment of an Asian Cancer Registry Network: problems and perspectives. Asian Pac J Cancer Prev 2008;9(4):815-832.
84 Parkin DM, Vatanasapt V. Cancer registration in Asia in the year 2000: past present and future. Asian Pac J Cancer Prev 2001;2(IACR Suppl):S1-S89.
85 Seo HJ, Oh IH, Yoon SJ. A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea. Asian Pac J Cancer Prev 2012;13(12):6163-6168.   DOI   ScienceOn
86 Higashi T, Nakamura F, Shibata A, Emori Y, Nishimoto H. The national database of hospital-based cancer registries: a nationwide infrastructure to support evidence-based cancer care and cancer control policy in Japan. Jpn J Clin Oncol 20-14;44(1):2-8.   DOI
87 Cho KH, Park S, Lee KS, Jang SI, Yoo KB, Kim JH, et al. A single measure of cancer burden in Korea from 1999 to 2010. Asian Pac J Cancer Prev 2013;14(9):5249-5255.   DOI   ScienceOn
88 Moore MA, Manan AA, Chow KY, Cornain SF, Devi CR, Triningsih FX, et al. Cancer epidemiology and control in peninsular and island South-East Asia: past, present and future. Asian Pac J Cancer Prev 2010;11 Suppl 2:81-98.
89 Zhao J, He YT, Zheng RS, Zhang SW, Chen WQ. Analysis of esophageal cancer time trends in China, 1989- 2008. Asian Pac J Cancer Prev 2012;13(9):4613-4617.   DOI   ScienceOn
90 Gao J, Xie L, Chen WQ, Zhang SW, Wu QJ, Yang Y, et al. Rural-urban, sex variations, and time trend of primary liver cancer incidence in China, 1988-2005. Eur J Cancer Prev 2013;22(5):448-454.   DOI
91 Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, Fujita M, et al. An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol 2013;43(5):492-507.   DOI
92 Kang MH, Park EC, Choi KS, Suh M, Jun JK, Cho E. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective? Asian Pac J Cancer Prev 2013;14(3):2059-2065.   DOI   ScienceOn
93 Norsa'adah B, Rahmah MA, Rampal KG, Knight A. Understanding barriers to Malaysian women with breast cancer seeking help. Asian Pac J Cancer Prev 2012;13(8):3723-3730.   DOI   ScienceOn
94 Cho E, Kang MH, Choi KS, Suh M, Jun JK, Park EC. Cost-effectiveness of Korea's National Cervical Cancer Screening Program. Asian Pac J Cancer Prev 2013;14(7):4329-4334.   DOI   ScienceOn
95 Cho E, Kang MH, Choi KS, Suh M, Jun JK, Park EC. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea. Asian Pac J Cancer Prev 2013;14(4):2533-2540.   DOI   ScienceOn
96 Suh M, Choi KS, Lee YY, Jun JK. Trends in cancer screening rates among Korean men and women: results from the Korean National Cancer Screening Survey, 2004-2012. Cancer Res Treat 2013;45(2):86-94.   DOI   ScienceOn
97 Moore MA, Kunimoto T, Tsuda H. Cancer screening literature in the period 2000-2002: pointers to future research avenues. Asian Pac J Cancer Prev 2003;4(1):57-60.
98 Komoto S, Nishiwaki Y, Okamura T, Tanaka H, Takebayashi T. Effect size and cost-effectiveness estimates of breast and cervical cancer screening reminders by population size through complete enumeration of Japanese local municipalities. BMC Public Health 2014;14:43.   DOI
99 Tabuchi T, Hoshino T, Nakayama T, Ito Y, Ioka A, Miyashiro I, et al. Does removal of out-of-pocket costs for cervical and breast cancer screening work? A quasi-experimental study to evaluate the impact on attendance, attendance inequality and average cost per uptake of a Japanese government intervention. Int J Cancer 2013;133(4):972-983.   DOI
100 Lee MH, Lee YY, Jung da W, Park B, Yun EH, Lee HY, et al. Effectiveness of interventions to increase the participation rate of gastric cancer screening in the Republic of Korea: a pilot study. Asian Pac J Cancer Prev 2012;13(3):861-866.   DOI   ScienceOn
101 Lee YY, Jun JK, Suh M, Park BY, Kim Y, Choi KS. Barriers to cancer screening among medical aid program recipients in the Republic of Korea: a qualitative study. Asian Pac J Cancer Prev 2014;15(2):589-594.   DOI
102 Ji MF, Huang QH, Yu X, Liu Z, Li X, Zhang LF, et al. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China. Cancer 2014;120(9):1353-1360.   DOI
103 Yang J, Wei WQ, Niu J, He YT, Liu ZC, Song GH, et al. Estimating the costs of esophageal cancer screening, early diagnosis and treatment in three high risk areas in China. Asian Pac J Cancer Prev 2011;12(5):1245-1250.
104 Choi KS, Jun JK, Park EC, Park S, Jung KW, Han MA, et al. Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One 2012;7(11):e50041.   DOI
105 Zhou L, Guan P, Sun LP, He QC, Yuan Y, Zhou BS. Health economic assessment for screening of gastric cancer in a high risk population in northeastern china. Chin J Cancer Res 2011;23(1):21-24.   DOI
106 Minamimoto R, Senda M, Jinnouchi S, Terauchi T, Yoshida T, Inoue T. Detection of colorectal cancer and adenomas by FDG-PET cancer screening program: results based on a nationwide Japanese survey. Ann Nucl Med 2014;28(3):212-219.   DOI
107 Naito Y, Uchiyama K, Kinoshita Y, Fukudo S, Joh T, Suzuki H, et al. A questionnaire-based survey on screening for gastric and colorectal cancer by physicians in East Asian countries in 2010. Digestion 2012;86(2):94-106.   DOI
108 Ito Y, Nakayama T, Miyashiro I, Ioka A, Tsukuma H. Conditional survival for longer-term survivors from 2000-2004 using population-based cancer registry data in Osaka, Japan. BMC Cancer 2013;13:304.   DOI   ScienceOn
109 Moore MA, Sobue T. Cancer research and control activities in Japan: contributions to international efforts. Asian Pac J Cancer Prev 2009;10(2):183-200.
110 Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132(5):1133-1145.   DOI   ScienceOn
111 Long N, Moore MA, Chen W, Gao CM, Lai MS, Mizoue T, et al. Cancer epidemiology and control in north-East Asia: past, present and future. Asian Pac J Cancer Prev 2010;11 Suppl 2:107-148.
112 Shin HR, Masuyer E, Ferlay J, Curado MP; Asian Contributors to CI5 IX4. Cancer in Asia: incidence rates based on data in cancer incidence in five continents IX (1998-2002). Asian Pac J Cancer Prev 2010;11 Suppl 2:11-16.
113 Shin A, Park S, Shin HR, Park EH, Park SK, Oh JK, et al. Population attributable fraction of infection-related cancers in Korea. Ann Oncol 2011;22(6):1435-1442.   DOI   ScienceOn
114 Bilyalova Z, Igissinov N, Moore M, Igissinov S, Sarsenova S, Khassenova Z. Epidemiological evaluation of breast cancer in ecological areas of Kazakhstan: association with pollution emissions. Asian Pac J Cancer Prev 2012;13(5):2341-2344.   DOI   ScienceOn
115 Wichajarn K, Kosalaraksa P, Wiangnon S. Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program. Asian Pac J Cancer Prev 2008;9(3):507-509.
116 Huang Y. China's position in negotiating the Framework Convention on Tobacco Control and the revised International Health Regulations. Public Health 2014;128(2):161-166.   DOI
117 Huang J, Zheng R, Chaloupka FJ, Fong GT, Li Q, Jiang Y. Chinese smokers' cigarette purchase behaviours, cigarette prices and consumption: findings from the ITC China Survey. Tob Control 2014;23 Suppl 1:i67-i72.   DOI
118 Hamashima C, Okamoto M, Shabana M, Osaki Y, Kishimoto T. Sensitivity of endoscopic screening for gastric cancer by the incidence method. Int J Cancer 2013;133(3):653-659.   DOI
119 Baek YJ, Shin DW, Choi JY, Kang J, Mo HN, Kim YH, et al. Late referral to palliative care services in Korea. J Pain Symptom Manage 2011;41(4):692-699.   DOI
120 Suh M, Choi KS, Lee YY, Park B, Jun JK. Cancer screening in Korea, 2012: results from the Korean National Cancer Screening Survey. Asian Pac J Cancer Prev 2013;14(11):6459-6463.   DOI   ScienceOn
121 Koo JH, Leong RW, Ching J, Yeoh KG, Wu DC, Murdani A, et al. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest Endosc 2012;76(1):126-135.   DOI   ScienceOn
122 Nawa T, Nakagawa T, Mizoue T, Kusano S, Chonan T, Hayashihara K, et al. A decrease in lung cancer mortality following the introduction of low-dose chest CT screening in Hitachi, Japan. Lung Cancer 2012;78(3):225-228.   DOI
123 Boonlikit S. Comparison of mammography in combination with breast ultrasonography versus mammography alone for breast cancer screening in asymptomatic women. Asian Pac J Cancer Prev 2013;14(12):7731-7736.   DOI
124 Bian ML, Cheng JY, Ma L, Cong X, Liu J, Chen Y, et al. Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening. Exp Ther Med 2013;6(5):1332-1336.   DOI
125 Moore MA. What and where for publications by cancer registries in the Asian Pacific?: roles for the APJCP in the future. Asian Pac J Cancer Prev 2013;14(8):4939-4942.   DOI   ScienceOn
126 Merriam S, Muhamad M. Roles traditional healers play in cancer treatment in Malaysia: implications for health promotion and education. Asian Pac J Cancer Prev 2013;14(6):3593-3601.   DOI   ScienceOn
127 Sriplung H, Wiangnon S, Sontipong S, Sumitsawan Y, Martin N. Cancer incidence trends in Thailand, 1989-2000. Asian Pac J Cancer Prev 2006;7(2):239-244.
128 Higashi T, Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, et al. Demonstration of quality of care measurement using the Japanese liver cancer registry. Hepatol Res 2011;41(12):1208-1215.   DOI